Quantcast
Channel: Health Care RSS Feed
Viewing all articles
Browse latest Browse all 24539

Axonics raises $35 million to treat overactive bladders

$
0
0
Axonics Modulation Technologies has added $20.5 million to its Series C, bringing the round to $35 million. The Irvine, California company previously closed $14.5 million of its Series C in early May. Axonics has developed the first rechargeable Sacral Neuromodulation (r-SNM) system to treat urinary and bowel dysfunction. The company will use the the new financing to conduct a pivotal clinical study in patients with overactive bladders to gain U.S. FDA approval. The study is expected to begin…

Viewing all articles
Browse latest Browse all 24539